Clinical trials

  • EPOETIN ALFA for Traumatic injury
  • andexanet alfa for Healthy volunteers
  • EMICIZUMAB for Hemophilia A
  • ALN-SNCA for Parkinson's disease
  • RILVEGOSTOMIG for Biliary tract adenocarcinoma|Intrahepatic cholangiocarcinoma|Extrahepatic cholangiocarcinoma|Gallbladder cancer
  • REMIBRUTINIB for Chronic inducible urticaria (CINDU) | Cold urticaria | Cholinergic urticaria | Symptomatic dermographism
  • Amoxicillin trihydrate for Penicillin allergy
  • GOZETOTIDE for Prostate cancer
  • sodium ({(2S)-1,4-bis[2-(4-chloro-3-fluorophenoxy)acetamido]bicyclo[2.2.2]octan-2-yl}oxy)methyl hydrogen phosphate-2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1/1) for Vanishing white matter disease
  • ZENAGAMTIDE for Overweight or obesity | Knee osteoarthritis
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Gastrointestinal cancers | Hepatocellular carcinoma | Cholangiocarcinoma | Gastric cancer | Pancreatic cancer | Colorectal cancer | Oesophageal cancer
  • COBICISTAT for Non-small cell lung cancer (EGFR-mutated)